Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 37.74
-0.60 (-1.56%)
Jan 21, 2026, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 13.55 billion as of January 21, 2026. Its market cap has decreased by -8.56% in one year.
Market Cap
13.55B
Enterprise Value
12.61B
Revenue
932.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.74
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 13.55B, a decrease of -34.37%. That is a compound annual growth rate of -7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 13.55B | 3.68% |
| Dec 31, 2025 | 13.06B | -16.21% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |